Date

August 27, 2025

Source

Nature

Categories

Gut microbiota profiles are associated with different spontaneous cortical activity in healthy older people

Introduction

During the last decades, a bidirectional relationship between the brain and the gut through what is called the gut-brain axis has been widely evidenced. In this regard, the gut microbiota has been shown to be altered in many Central Nervous System (CNS)-related co-morbidities. However, is there a relation between gut microbiota and brain activity in healthy conditions in any way?

The gut microbiota is the set of microorganisms that reside in the intestinal environment. The gut microbiota is considered an organ of the gastrointestinal tract that provides additional genes and functions to the genetic resources of the human species and is involved in multiple physiological processes (nutrition, development, immunity, etc.)1. Several essential functions carried out by the microbiota, such as the transformation of non-digestible food components into absorbable metabolites, the synthesis of essential vitamins, the elimination of toxic compounds, the strengthening of the intestinal barrier, or the regulation of the immune system, demonstrate its importance2.

Human gut microbiota matures and changes throughout our life cycles, from childhood to old age, and is a fundamental element in protecting our health. When the adult stage is reached, there is a stable community specific to each individual with dominant and subdominant bacterial species, although the abundance of different bacteria may fluctuate in response to external factors (diet, medications, travel, etc.)3. Thus, gut microbiota has particularities and characteristics specific to each individual, and may vary according to genetic endowment, diet, drugs, geography, and interaction with the environment4.

In order to identify patterns related to both human healthy and pathologic conditions, a series of reproducible profiles of gut microbiome variation in healthy adults, known as enterotypes, have been established, which are composed of a number of characteristic bacterial groupings. Three normality enterotypes have been proposed, based on the co-occurrence of different genus of microorganisms where one genus stands out from the rest5,6: enterotype 1, being Bacteroides the prevalent indicator; enterotype 2, led by Prevotella; and enterotype 3, with abundance of Ruminococcus. Any other combination of maladaptive and pathogenic microorganisms, together with a decreased biodiversity, can be considered intestinal dysbiosis.

In recent years, the number of preclinical and clinical studies that find relationships between pathological changes in the intestinal microbiota and neurological (Parkinson’s disease, Alzheimer’s disease) and mental (depression, stress, autism) diseases has grown significantly7,8,9,10,11, giving rise to the theory that a balanced microbiota is essential to maintain a healthy state. All these diseases share chronic inflammation, likely resulting from microbial dysbiosis, which points to the intestinal microbiota as a key factor in the onset of these disorders12.

The idea that the gut microbiota may have a significant impact on the CNS and neuroinflammation and, consequently, on neurological and behavioral disorders, is framed within the gut-brain axis research domain. This axis represents the bidirectional pathway of communication between the gut microbiota and the CNS.

There are several studies focusing on the direction from the gut to the brain that analyze whether the intake of different products, which modify gut composition, can affect spontaneous brain activity, cognitive function, anxiety, or stress. In13,14, subtle changes in the resting electroencephalographic (EEG) signal of brain regions associated with memory, attention, and inflammatory response, among others, were identified as a result of a psychobiotic intake by healthy subjects. Another study in children, who were in intensive care at birth and took antibiotics, showed that they presented greater power in a low-frequency band of their electroencephalogram in contrast to other children without antibiotic exposure15. In the same line of research, in16, a review of the modification of EEG rhythms, in the most clinically relevant frequency bands, based on the alterations present in the intestinal microbiota of people with metabolic diseases (obesity, diabetes), is carried out.

A functional magnetic resonance imaging (fMRI)-based study showed that the activity of brain regions involved in the control of emotion and sensation processing can be modulated in healthy women with the consumption of probiotic-fermented milk for 4 weeks17. Some longitudinal studies have also shown that administration of multi-strain probiotics reduces depression and improves attention in healthy volunteers by modifying brain functional connectivity, processed from resting-state fMRI and diffusion tensor imaging (DTI)18.

All these reviewed works have as a common goal to examine brain activity changes in relation to microbiota changes resulting from some nutritional or pharmacological intervention. These scientific studies of the gut-brain axis provide evidence on the influence of the microbiota on brain and behavior through the combined application of both neuroimaging (fMRI, EEG, DTI) and microbiota sequencing techniques.

This paper first presents an exploratory study that intends to characterize the relation between spontaneous brain activity in healthy older people, that is, with no metabolic, intestinal, and neurological disease, and their gut microbiota profiles. In a second step, the cognitive functions associated with this activity will be analyzed in order to identify possible cognitive disorders. Positive findings would facilitate and promote further research on preventing, delaying, or attenuating the onset of these disorders through simple nutritional interventions that modulate the gut microbiota.

Results

Microbiota-based clusters

Three clusters were identified by the X-Means clustering algorithm (A, B, and C) based on the microbiota relative population (%) at the genus level, composed of 26, 22, and 6 participants, respectively. Table 1 shows the average (standard deviation) values of the demographic and depression-related variables, together with the statistics of the differences between them. In this sense, the clusters did not present any significant difference in age, sex, body mass index, depression- and anxiety-related scores between them. The blood tests and anthropometrical data are shown in Table S1. Statistically significant differences between clusters are present in scattered parameters such as mean corpuscular volume (MCV) (p = 0.003) and Mean Corpuscular Hemoglobin (MCH) (p = 0.004). Also, adrenaline values are significantly higher in group C compared with group B (p = 0.004).

Table 1 Average (standard deviation)/Percentage (#) values of the sociodemographic variables of the participants in the three microbiota-based clusters and the statistics of the main effect.

Full size table

To test the influence of the X-Means criterion of the optimum number of clusters on the resultant distribution, the algorithm was also executed with fixed numbers of clusters of 2 and 4. In the former case, clusters A and B were grouped as one while cluster C remained the same. In the latter case, cluster A was split into two subclusters, and clusters B and C remained the same. Therefore, the inner distribution was kept regardless of the number of clusters.

Microbiota differences between microbiota-based clusters

After obtaining the microbiota-based clusters, we conducted an analysis to determine the pairwise differences in bacterial relative abundance between them.

Figure 1a and Table S2 show the bacterial genera that presented significant statistical differences between clusters. According to Table S2, cluster B had a higher proportion of Bacteroides than clusters A and C. Besides, the proportion of Prevotella 9, Mycobacterium, Holdemanella, Coriobacteriaceae UCG-003, Libanicoccus, Lactiplantibacilus, Luenostoc, and Stenotrophomonas is higher in cluster C than in the other two clusters. Cluster B contained a higher proportion of Barnesiella and Ruminococcus (gnavus group) than cluster A, whereas cluster A presented a higher proportion of Marvinbryantia and other genera than cluster B.

Fig. 1
figure 1

(a) Average log relative occurrence (%) of the bacterial genera that presented statistically significant differences between clusters A, B, and C after post-hoc correction. Brackets with an asterisk denote a statistically significant post-hoc difference between the linked clusters in the corresponding bacteria genus of the x-axis. Main effects: F(2,48) > 3.210, p < 0.49, N(A) = 26, N(B) = 22, N(C) = 6. (b) Microbiota diversity for the three clusters of the bacterial genera that presented statistically significant differences between them. Error bars denote standard deviation. (c) Scatterplots of the three clusters according to the relative abundance of Bacteroides, Prevotella 9 and Barnesiella (left), and Marvinbryantia (right).

Full size image

Summarizing (Fig. 1b, c), the microbiota of cluster C is mainly composed of Prevotella 9 and then Bacteroides in an inverse relation. The microbiota of cluster A is mainly composed of Bacteroides and then Prevotella 9. Despite the microbiota of cluster B being mainly composed of Bacteroides too (significantly higher than in the other two clusters), the second most abundant bacterial genus in this cluster is not Prevotella 9, like in cluster A, but Barnesiella. Cluster A, however, presents more abundance of Marvinbryantia. Moreover, the presence of Mycobacterium, Leuconostoc, and Stenotrophomonas was evident in cluster C, in contrast to clusters A and B. However, clusters A and B evidenced the presence of Ruminococcus (gnavus group), in contrast to cluster C.

According to the three enterotypes defined by Arumugam et al.5 and Costea et al.6, the gut microbial composition of the clusters A and B found in the current study fits to the enterotype 1, since the genus Bacteroides is the most abundant, and cluster C meets the criteria defining enterotype 2, where Prevotella is the most abundant and is inversely correlated with Bacteroides.

Spontaneous cortical activity differences between microbiota-based clusters

Analogously to the former section, we examined the pairwise differences in spontaneous brain activity between the previously obtained microbiota-based clusters. We performed this analysis for three EEG frequency bands (theta, alpha, and beta) and two conditions (eyes open and eyes closed) separately.

Tables S3 and S4 show the cortical areas of the Brainnetome atlas that presented a statistically significant main effect of cluster in eyes closed and eyes open conditions, respectively.

The spontaneous brain activity between clusters A and B (Fig. 2) only differs significantly in the right inferior frontal sulcus, Brodmann areas (BAs) 9 and 46, in the low alpha band (B more active than A), in the eyes open conditions.

Fig. 2
figure 2

P color-coded values of the statistically significant differences in normalized EEG source density between microbiota-based clusters A and B after post hoc correction, in the eyes open condition for different brain areas (according to the Brainnetome atlas) and frequency bands. Main effect: χ2(2) = 9.131, p = 0.01, N(A) = 26, N(B) = 22. LH: Left hemisphere; RH: Right hemisphere.

Full size image

The differences of brain activity between cluster C, and clusters A and B were very similar (Figs. 3 and 4). Cluster C showed a higher activity than clusters A and B in the posterior cingulate cortex and the precuneus, bilaterally, and the left fusiform gyrus in the theta band during the eyes closed condition. During the eyes open condition, only the left posterior cingulate area and the left precuneus presented more activation in cluster C than in clusters A and B.

Fig. 3
figure 3

P color-coded values of the statistically significant differences in normalized EEG source density between microbiota-based clusters A and C after post hoc correction, in eyes open (a) and eyes closed (b) conditions for different brain areas (according to the Brainnetome atlas) and different frequency bands. Main effects: χ2(2) > 9.204, p < 0.01, N(A) = 26, N(C) = 6. LH: Left hemisphere; RH: Right hemisphere.

Full size image

Fig. 4
figure 4

P color-coded values of the statistically significant differences in normalized EEG source density between microbiota-based clusters B and C after post hoc correction, in eyes open (a) and eyes closed (b) conditions for different brain areas (according to the Brainnetome atlas) and different frequency bands. Main effects: χ2(2) > 9.204, p < 0.01, N(B) = 22, N(C) = 6. LH: Left hemisphere; RH: Right hemisphere.

Full size image

The particular difference between the brain activation of clusters C and B (Fig. 4) is the higher activity of cluster B in the right superior primary motor cortex (M1) in the beta band, during the eyes open condition.

Cognitive functions associated with the areas with activity differences between clusters

Given that the EEG activity of the participants was recorded at rest, we cannot assign a functionality to the significant ROIs from our data. Consequently, we used a meta-analysis-based approach to identify the cognitive functions associated with those ROIs, the so-called activation likelihood estimation (ALE19), which computes a probabilistic estimation from the activation of brain foci in experiments reported in the literature.

Figure 5 shows the ALE of the areas that significantly differed between clusters A and B (Fig. 5a), A and C, and B and C (Fig. 5b), during cognitive tasks according to brainmap.org. Note that Fig. 5b is a single figure for A-C and B-C differences because the ROIs affected in both cases are the same. Given the functional estimations, the only area significantly different in spontaneous activity between clusters A and B (Fig. 5a) is mainly activated during pain perception and working memory usage.

Fig. 5
figure 5

(a) Color-coded activation likelihood estimation (ALE) of the cortical areas (and average and number) that presented significant differences between clusters A and B; (b) cluster C and clusters A and B aggregated, during the tasks according to the brainmap.org taxonomy.

Full size image

With respect to the areas with different activity between clusters A-B and C (Fig. 5b), they are also mostly related to episodic memory, language, and social cognition. However, other areas are also related to action perception and processing, cognition, and emotion processing.

This analysis reveals differences in memory, language, emotion processing, and action skills among the three microbiota profiles identified in the sample based on their associated spontaneous brain activity.

Linear modelling of brain regions of interest (ROIs) activity from microbiota

In order to further test for the association between the gut microbiota abundance and the spontaneous brain activity in the ROIs presenting differences between clusters, we performed a linear modelling analysis of the sum of those ROIs’ activity, taking subsets of the relative abundance of microbiota genera as predictors.

Linear models of the sum of ROIs activity in the theta band eyes closed (Figs. 3b and 4b), theta band eyes open (Figs. 3a, and 4a), alpha band eyes open (Fig. 2), and beta band eyes open (Fig. 4a, bottom left) were constructed. The only significant model found was the one for the sum of the source density in the theta band, eyes closed, adjusted R2 = 0.846, F(13) = 16.945, p < 0.0005. Figure 6 shows the scatterplot (a) of the model fitting and the relative contribution of the predictors to the model (b). All the predictors contributed significantly to the model (p < 0.05).

Fig. 6
figure 6

Linear model of the sum of the source activity of the ROIs that presented significant differences between clusters in the theta band with eyes closed. (a) Model fit. Colored points correspond to the different microbiota-based clusters. F(13) = 16.945, p < .0005, N = 54. (b) Relative contribution of each predictor to the model. Red negative bars indicate a negative coefficient, not a negative importance index.

Full size image

The linear model indicates that the source density in the theta band during the eyes closed condition can be estimated from the abundance of some bacterial genera. The most contributing genus to the model was Prevotella 9, which in turn presented significant differences between clusters A and C, and B and C. This result points to the relative abundance of Prevotella 9 as one of the sources of the difference in brain activity in the identified ROIs between clusters.

Discussion

In this article, a study on healthy older subjects is presented in which the result of the analysis of their gut microbiota showed three groups with statistically significant differences in composition and abundance, mainly in the Prevotella 9, Bacteroides, Mycobacterium, Holdemanella, and Barnesiella genera. The analysis of their spontaneous electroencephalographical activity also showed significant differences between subjects in the three groups, especially between two of them (A, B) and the third one (C), covering the precuneus, the posterior cingulate cortex bilaterally, and the left fusiform area, all in the theta band. The hypothesis underlying the findings of this study on the observed differences in brain activity among the different groups of gut microbiota is that each gut microbiota profile could modulate differently the vagus nerve (VN) signal and, so, produce the specific brain activity found in each group. This hypothesis is supported by the scientific literature about the structure and dynamics of the VN, detailed in the next paragraphs.

Although the specific mechanisms of the interaction between the intestinal microbiota and the brain are still unraveled, the VN represents perhaps the most direct and fastest neural communication link between the gut microbiota and the brain4. Other major routes of this bidirectional axis are the immune system, which is activated by the microbiota and releases cytokines that circulate in the bloodstream and influence the CNS through the blood–brain barrier, and the neuroendoncrine system by regulating tryptophan metabolism and neurotransmitter production such as glutamate, butyrate, dopamine, serotonin and gamma aminobutyric acid (GABA), which are key neurotransmitters in many conditions20. Besides, microbial metabolites can also affect the brain dynamics directly, by producing, for instance, short-chain fatty acid (SFCA) that regulates neuroplasticity, or indirectly, by synthesizing some specific neurotransmitters and enzymes21.

There are preclinical and clinical evidences on the role of the VN in inflammatory processes that could contribute to the development of certain neurodegenerative diseases as Parkinson’s disease22 and mental disorders affecting emotion and cognition, such as depression23 or autism spectrum disorder24. On the other hand, vagus nerve stimulation (VNS) has demonstrated therapeutic benefits in CNS-related diseases such as epilepsy and depression25. The modulation of the VN, through stimulation and modification of the signal it transmits, might be the mechanism used by the gut microbiota to activate gut vagal afferent fibers and reach the brain. Several studies concerning the neurobiology involved in the response to VNS have revealed the existence of a neural circuit that can be considered as the afferent brain network of the VN signal26.

One of the key mechanisms to encode sensory information in the gut are by vagal afferent endings, located in the muscular layer and in the mucosa of the intestine, which are mechanical and chemical sensitive to gut stimuli or condition27,28. Accordingly, these terminals can detect and reply to gut muscular tone or inflammation4 and have an electrophysiological response to the presence of cytokines, nutrients, peptides, and hormones in the epithelial layer of the intestine. In addition, some bacteria can produce neurotransmitters such as serotonin, which, when absorbed, can act directly on the VN endings or, indirectly, through activation of enteric neurons29. Thus, either mechanically or chemically, the gut microbiota is involved in VN signaling21.

From the anatomical point of view, VN afferent fibers from the gut contact bilaterally with the Nucleus Tractus Solitarius (NTS)25. The physiological and functional role of the NTS is mainly based on the study of the vagus nerve stimulation (VNS) effects. A model of plausible vagal pathways implicated in the brain activity proposed in30, founded on several different noninvasive transcutaneous VNS (tVNS) fMRI studies on healthy people, confirms that, once VNS activates the structures of the lower brainstem as NTS, this one transmits activation to upper brainstem areas as the locus coerelus (LC) and dorsal raphe nucleus (DRN). The activation of LC produces norepinephrine that modulates large-scale brain networks involved in cognitive functions like memory, attention, emotion, or stress reaction. Also, a review of several studies contained in25 also validates how the vagal stimulation applied to either healthy or neurological impaired people impacts the LC activity, increasing the release of neurotransmitters as norepinephrine. At the cortical level, this pathway may reconfigure the activity of the insula, the dorsolateral and dorsomedial prefrontal cortices, and the sensory cortex. Furthermore, the activation of DRN produces serotonin, which selectively affects brain regions of the limbic system such as the ACC, the posterior cingulate cortex (PCC), and the dorsomedial prefrontal cortex (dmPFC). The PCC is one of the cortical areas involved in our study, whose activity differs between gut microbiota-based cluster C and clusters A and B.

Another anatomical model explaining the modulation of the brain activity and functional connectivity by tVNS is proposed in31. The model collects evidence from different studies with healthy participants showing that the stimulation of VN changes the activation in the insula, precentral gyrus, PCC, ACC, prefrontal and frontal cortices, S1, and parahippocampal gyrus. Again, this model shows that the PCC activation is affected by VN signaling.

Regarding the functional implications of the mentioned brain ROIs, VNS has also been studied to find its influence on cognitive functions in healthy people by analysing the neural pathways engaged in VNS action. In32, synchronized fMRI and tVNS were acquired to analyse the effects of VNS on brain activity and cognitive performance. This work showed that VNS results in a better performance on memory and language skills, and produces correlated significant spontaneous brain activity changes on the calcarine gyrus, fusiform gyrus, lingual gyrus, and parahippocampal gyrus. In addition, tVNS enhances recognition of emotions in faces33, resulting from the increased activity in the left fusiform gyrus34,35. In our study, this cortical region has a higher activity in cluster C.

In older healthy people, tVNS improves associative memory performance based on the hypothesis that tVNS modulates the memory using similar mechanisms to how emotion affects memory: emotional arousal increases the level of adrenalin that activates afferent VN fibers, and these activate the LC, which releases noradrenalin to the hippocampus and the amygdala that are brain areas involved in memory formation and consolidation36. Other neuroimaging studies revisited in32 point to the precuneus as a cortical brain area involved in visuospatial imagery, contextual memory, and information processing, among others, and to the parahippocampal gyrus as the main cortical input to the hippocampus. Both regions are significantly activated when tVNS is applied. In our study, the precuneus activity is also higher in the cluster C regarding clusters A and B.

Finally, the main areas that presented differences in spontaneous activity between microbiota-based clusters in our study, the precuneus and the PCC, are considered as a central hub part of the posterior default mode network (DMN)37. In the absence of pathology, these areas have been traditionally related to functions such as visuo-spatial imagery, episodic memory, and self-processing38, although the participation in working memory, reward, and fear processing has also been recently evidenced39. However, given their widespread functional and structural connections and their high relative metabolic rate40, any disorder in them might lead to a variety of cognitive changes41. As a matter of fact, the precuneus and PCC have been pointed out as key vulnerable areas for several neuropathologies and psychiatric disorders39.

Regarding the clusters A and B, the area that presented a difference in spontaneous activity between them, the right inferior frontal sulcus (IFS), BAs 9 and 46, is mainly implicated in working memory. Differences in cortical thickness in that area due to age were evidenced to correlate with working memory performance42. Given also that the IFS is an area differentially affected by ageing43, the different activity between clusters A and B could point to a difference in healthy brain ageing (despite no difference in chronological age). Again, this needs further research.

Caution is required when interpreting the results of our study. Cluster C is the one that presented more differences in microbiota and spontaneous EEG with respect to the other two clusters. However, cluster C is only composed of six participants. Despite the statistical significance is high for the differences found, a larger sample (especially for this cluster), and thus further research, would be needed to extrapolate the conclusion to the general coetaneous population. Nonetheless, cluster C is covering a singular set of participants in terms of microbiota abundance, since the selection of a different number of clusters (either lower or higher than 3) always yielded the same cluster C, and just split or grouped participants in clusters A and B. Although the findings were consistent, the sample size of this study was relatively limited, and we simply lacked power to detect additional associations. This may explain, at least in part, why associations of cluster C at the majority of biochemistry or anthropometric measures were not observed. Regarding MCH, MCV and adrenaline, differences in related parameters have been reported in the literature associated to some of the most predominant bacterial genera of the enterotypes described here44,45. Our results do not allow for any conclusions in this phase. A more comprehensive and detailed study of the role of each cluster in specific brain behaviors, catecholamines, and blood parameters would be needed. Besides, the assumption that different gut microbiota composition leads to signal-specific brain cortical areas in a distinct way mediated by the vagus nerve does not necessarily imply that gut microbiota is the sole cause of the brain activity differences, nor that the vagus nerve is the only link between gut microbiota and brain20,46. It is necessary to keep on making studies that include more factors that can have an impact on gut microbiota, brain activity, and behaviour, as pointed out in47. Moreover, since microbiota influences the brain through metabolites to a great extent48, an analysis of these could reveal and/or support the relation between the microbiota genera and the activation of the brain ROIs found in the present study. For instance, in our case, the elevated Prevotella 9 in cluster C would shift SCFA production toward higher propionate levels, which can be 2–fourfold higher in Prevotella compared to Bacteroides-dominant clusters49. Propionate is a known precursor for hepatic glucose production, which has been reported to suppress feeding behaviour in ruminant studies through the stimulation of hepatic vagal50. This vagal signaling pathway could indirectly affect PCC and precuneus function through their connections with brainstem areas that receive vagal input, as commented above. Besides, the PCC presents a high rate of metabolism. In the human, cerebral blood flow and metabolic rate are  40% greater than average within the PCC and adjacent precuneus40. Given that propionate can serve as an energy substrate and acetate serves as an important energy source for host cells, particularly in the brain and peripheral tissues51, we could plausibly hypothesize that elevated propionate levels could potentially alter the metabolic activity in these highly metabolically active regions, thus explaining the differences in cortical activity between cluster C and clusters A and B. This, of course, would need further research to be confirmed.

Summarizing, this paper presents the first study to assess the relation between gut microbiota and spontaneous brain activity measured by resting-state EEG in healthy senior people. We have reported two main findings: (1) gut microbiota composition in healthy subjects could impact on brain activity, as suggested by two procedures based on a cluster analysis and on a linear model; and (2) the affected brain activity could influence the aging process of the memory, language, and social cognition, given the brain areas in which the brain activity showed differences.

Methods

Participant recruitment and sample collection

The recruitment was performed through the GENYAL Clinical Trials Platform at IMDEA Food Institute. This study was approved by the institutional Research Ethics Committee (protocol ID: IMD PI-055, IMDEA Food Foundation) and performed following the principles of research involving human subjects stated in the Declaration of Helsinki (1964) and Good Clinical Practice (GCP). All participants were clearly informed about the study methodology and provided written informed consent.

Anthropometric measurements, peripheral blood samples, and fecal samples were collected from a total of fifty-four healthy participants over 55 years of age (Male: 21, Female: 33). Sampling and data acquisition were performed between October and November 2022.

Inclusion criteria included: Age ≥ 55 years; BMI between 27 and 35 kg/m2; able to understand the informed consent; willing to comply with the study protocol. Exclusion criteria included: decreased cognitive function, pregnancy or breastfeeding, severe chronic health conditions (heart, liver, etc.), BMI > 35 kg/m2, or pharmacological treatment such as anxiolytics, antidepressants, medication for sleep disorders, or any type of psychotropic medication.

Anthropometric measurements

Anthropometric measurements were collected following standardized methodology. Body Composition Monitor analyzer (BF511- OMRON HEALTHCARE UK, LT, Kyoto, Japan) was used to determine weight, % body fat, % skeletal muscle, and visceral fat, as well as basal metabolic rate. Height was measured with a stadiometer (Leicester-Biological Medical Technology SL, Barcelona). Waist and hip circumference (cm) were measured using Seca 201 (Quirumed, Valencia, Spain). Blood pressure and pulse were monitored with the Model M3 blood pressure monitor from OMRON HEALTHCARE UK, LT, Kyoto, Japan).

Behavioral measures: sleep habits (OSQ questionnaire), emotional state (DASS-21 questionnaire), and mental state (MMSE questionnaire)

OSQ

Sleep habits were assessed via the Oviedo Sleep Questionnaire (OSQ)52. The OSQ is a validated interview that supports diagnosis of insomnia and hypersomnia during the previous month based on the DSM-IV and ED-10 criteria. The questionnaire is made up of a total of 15 items, including Subjective satisfaction with sleep, Insomnia (difficulty with falling or remaining asleep, early awakenings, or restorative sleep, among others), and hypersomnia (daytime sleepiness and its effects on daily tasks).

DASS-21

The psychological state of the participants was measured using the short version of the Depression, Anxiety and Stress Scale (DASS-21)53. Designed to assess the emotional states of depression, anxiety, and stress. The DASS-21 consists of 21 items, divided into three subscales of 7 Likert items. A score for each scale is calculated by summing all the related items, and these scores are later added to obtain a general score.

MMSE

The Mini-Mental State Examination (MMSE) (Spanish version) is a widely utilized cognitive screening tool designed to assess cognitive impairment and dementia54,55. The MMSE evaluates five cognitive domains: orientation, registration, attention and calculation, recall, and language. The total score has a maximum punctuation of 35, with lower scores indicating greater cognitive impairment.

Fecal samples processing and 16S sequencing

Sample collection and DNA extraction

Fecal samples were sent to Novogene for 16S sequencing of the bacterial V3V4 region and further analyses: DNA was extracted by using the Magnetic Soil and Stool DNA Kit (TianGen, China, Catalog #: DP712), following the manufacturer’s protocol to ensure high-quality and high-yield DNA suitable for downstream applications.

PCR amplification of 16S rRNA gene

The 16S rRNA gene was amplified using a set of universal primers targeting the V3-V4 regions of the 16S rRNA gene. The primers used were (5′- CCTAYGGGRBGCASCAG-3′) and (5′- GGACTACNNGGGTATCTAAT-3′), which are known for their broad coverage of bacterial taxa while minimizing amplification of eukaryotic rRNA genes. The PCR conditions were optimized to ensure specific amplification, with an initial denaturation at 98 °C for 1 min, followed by 30 cycles of denaturation at 98 °C for 10 s, annealing at 50 °C for 30 s, and extension at 72 °C for 30 s, with a final extension at 72 °C for 5 min.

High-throughput sequencing

The amplified 16S rRNA gene fragments were performed by using specific primers connecting with barcodes. The PCR products of the proper size were selected through 2% agarose gel electrophoresis. The same amount of PCR products from each sample was pooled, end-repaired, A-tailed, and further ligated with Illumina adapters. Libraries were sequenced on a paired-end Illumina platform to generate 250 bp paired-end raw reads.

Data processing and analysis

Raw sequencing data were processed using the DADA2 pipeline, which includes quality filtering, dereplication, chimera removal, and sequence variant inference. This method allows for the recovery of full-length 16S rRNA gene sequences with single-nucleotide resolution and a near-zero error rate, ensuring high accuracy in microbial community profiling.

Taxonomic assignment and relative abundance calculations

Taxonomic classification of the ASVs (Amplicon Sequence Variants) was performed using the SILVA database, which provides comprehensive and up-to-date taxonomic information for 16S rRNA gene sequences. The classification was done at various taxonomic levels, including phylum, class, order, family, genus, and species.

By applying QIIME2’s classify-sklearn algorithm, a pre-trained Naive Bayes classifier is used for species annotation of each ASV. Then, the DADA2 method is mainly used for noise reduction.

According to the results of ASVs’ annotations and the feature tables of each sample, the species abundance tables at the level of kingdom, phylum, class, order, family, genus, and species are obtained. However, for posterior analysis species-level assignments were excluded for several reasons: (i) the sequenced 16S rRNA gene regions (V3-V4) lack sufficient variability to reliably distinguish closely related species, (ii) the available reference databases may not have comprehensive or well-curated species-level information for all taxa, (iii) species-level assignments can be noisy and prone to misclassification because of sequencing errors, natural intra-species variation, or horizontal gene transfer, (iv) Aggregating ASVs to genus level reduces sparsity (many zeros) in abundance tables, which improves statistical power and interpretability; and the genus-level assignment was chosen for relative abundance analyses.

The relative abundance of a given genus in a given sample is calculated as the number of detections of this genus in the sample over the total number of detections of all genera in that sample.

EEG data acquisition

The participants were comfortably seated with their forearms resting on their thighs, one meter away from a white wall. They were asked to relax and breathe deeply with their mouth naturally open during three-minute periods, first with eyes closed and then with eyes open staring at the wall, with a one-minute resting interval between the two conditions. The EEG signal was acquired from 32 wet active ActiCAP electrodes (Brain Products GmbH, Gilching, Germany) placed on the scalp in the positions Fp1, Fp2, AF3, AF4, F7, F3, Fz, F4, F8, FC5, FC1, FC2, FC6, T7, C3, Cz, C4, T8, CP5, CP1, CP2, CP6, P7, P3, Pz, P4, P8, PO3, PO4, O1, Oz, O2 according to the 10–20 system. Reference was set to the Fz electrode and ground to the Fpz electrode. The signal was digitized and recorded by an actiChAmp amplifier (Brain Products GmbH, Gilching, Germany) at 256 Hz. The impedance of all electrodes was kept under 10 kΩ.

EEG processing

The EEG signal was preprocessed offline by a custom script in MATLAB R2019b (The MathWorks Inc., Natick, MA, USA) using the EEGLAB56 functions. The signal was first cleaned by using Artifact Subspace Reconstruction (ASR)57, rejecting burst intervals above a threshold of 20 standard deviations (all the other parameters set to default). Then, the signal was bandpass filtered between 3 and 31 Hz. After that, eye- and muscle-related artifacts were removed by IClabel58 with thresholds above 70% of probability. Next, bad channels were interpolated using the default parameters of the PREP pipeline59. Finally, the signal was rereferenced to the average value among all channels.

Source density in six frequency bands (theta: 4 Hz–7 Hz; low alpha: 7 Hz–10 Hz; high alpha: 10 Hz–13 Hz; low beta: 13 Hz–18 Hz; mid beta: 18.5 Hz–21 Hz; high beta: 21 Hz–30 Hz) was calculated from the preprocessed signal by the eLORETA algorithm60 implemented in the LORETA-KEY software v20221229 (KEY Institute for Brain-Mind Research, Zurich, Switzerland). Source density was averaged for each of the 210 cortical areas defined by the Brainnetome atlas61.

Data and statistical analysis

Participants were clustered from their microbiota population (at genus level) by the X-Means algorithm62, which automatically determines the optimum number of clusters (maximum intra-cluster, minimum inter-cluster similarity) based on the Bayesian Information Criterion (BIC). No standardization was applied to the data before clustering because we selected a non-scale-sensitive metric, the cosine distance, for measuring the similarity between clusters during the X-Means iterations, which guarantees that the clustering process is not affected by the difference of variance or range between the variables.

Differences in socio-demographic variables and microbiota population were tested by MANOVA tests, after confirmation of normality with the Shapiro–Wilk test and Q–Q plots. Post-hoc pairwise comparisons were performed with Tukey’s method after confirmation of a significant main effect of cluster. Differences in categorical variables were tested by the Chi-squared test. Significance was considered with p < 0.05. Effect size was reported as partial eta squared.

Differences in EEG source densities between clusters were tested by the Kruskal–Wallis test, after confirmation of non-normality by the Shapiro–Wilk test and Q-Q plots. Significance was considered with p < 0.01 in this case. Post-hoc pairwise comparisons were performed with Bonferroni’s correction after confirmation of the significant main effect of cluster. All the above analyses and tests were performed with SPSS v29.0.2.0 (Armonk, NY: IBM Corp.).

Finally, linear regression models were applied to predict the source density sum of the ROIs that presented significant differences between clusters. For that purpose, the automatic linear modelling procedure of the SPSS suite was applied, setting the number of predictors to the number of bacteria genera that presented significant differences between clusters, and the Akaike Information Criterion (AIC) as model fit index. Models with p < 0.05 (ANOVA) were considered statistically significant. The importance of each predictor was calculated as the residual sum of squares with the predictor removed from the model, normalized so that all the importance values sum up to 1.

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Senchukova, M. A. Microbiota of the gastrointestinal tract: friend or foe?. World J. Gastroenterol. 29(1), 19–42. https://doi.org/10.3748/wjg.v29.i1.19 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target Ther. 7(1), 135. https://doi.org/10.1038/s41392-022-00974-4.PMID:35461318;PMCID:PMC9034083 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Tochitani, S. Vertical transmission of gut microbiota: Points of action of environmental factors influencing brain development. Neurosci. Res. 168, 83–94. https://doi.org/10.1016/j.neures.2020.11.006 (2021).

    Article  CAS  PubMed  Google Scholar 

  4. Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99(4), 1877–2013. https://doi.org/10.1152/physrev.00018.2018 (2019).

    Article  CAS  PubMed  Google Scholar 

  5. Arumugam, M., et al. Enterotypes of the human gut microbiome. Nature. 2011 May 12;473(7346):174–80. https://doi.org/10.1038/nature09944. Epub 2011 Apr 20. Erratum in: Nature. 2011 Jun 30;474(7353):666. Erratum in: Nature. 2014 Feb 27;506(7489):516. PMID: 21508958; PMCID: PMC3728647 (2014).

  6. Costea, P. I., et al. Enterotypes in the landscape of gut microbial community composition. Nat Microbiol. 2018 Jan;3(1):8–16. https://doi.org/10.1038/s41564-017-0072-8. Epub 2017 Dec 18. Erratum in: Nat Microbiol. 2018 Mar;3(3):388. https://doi.org/10.1038/s41564-018-0114-x (2018).

  7. Bosch, J. A. et al. The gut microbiota and depressive symptoms across ethnic groups. Nat. Commun. 13(1), 7129. https://doi.org/10.1038/s41467-022-34504-1 (2022).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dogra, N., Mani, R. J. & Katare, D. P. The gut-brain axis: two ways of signaling in Parkinson’s disease. Cell. Mol. Neurobiol. 42(2), 315–332. https://doi.org/10.1007/s10571-021-01066-7 (2022).

    Article  CAS  PubMed  Google Scholar 

  9. Radjabzadeh, D. et al. Gut microbiome-wide association study of depressive symptoms. Nat. Commun. 13(1), 7128. https://doi.org/10.1038/s41467-022-34502-3 (2022).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tarawneh, R. & Penhos, E. The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions. Neurosci. Biobehavior Rev. https://doi.org/10.1016/j.neubiorev.2022.104814 (2022).

    Article  Google Scholar 

  11. Fernández-Calvet, A. et al. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nat. Commun. 15(1), 4150. https://doi.org/10.1038/s41467-024-48309-x (2024).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  12. Spielman, L. J., Gibson, D. L. & Klegeris, A. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases. Neurochem. Int. 120, 149–163. https://doi.org/10.1016/j.neuint.2018.08.005 (2018).

    Article  CAS  PubMed  Google Scholar 

  13. Allen, A. P. et al. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology, and neurocognition in healthy volunteers. Transl. Psychiatry 6(11), e939. https://doi.org/10.1038/tp.2016.191 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kelly, J. R. et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav. Immun. 61, 50–59. https://doi.org/10.1016/j.bbi.2016.11.018 (2017).

    Article  CAS  PubMed  Google Scholar 

  15. Firestein, M. R. et al. Perinatal antibiotics alter preterm infant EEG and neurobehavior in the family nurture intervention trial. Dev. Psychobiol. 61(5), 661–669. https://doi.org/10.1002/dev.21820 (2019).

    Article  PubMed  Google Scholar 

  16. Toderean, R., Dimian, M. & Cobuz, C. EEG changes related to gut dysbiosis in diabetes—Review. Appl. Sci. 11(24), 11871. https://doi.org/10.3390/app112411871 (2021).

    Article  CAS  Google Scholar 

  17. Tillisch, K. et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144(7), 1394-1401.e14014. https://doi.org/10.1053/j.gastro.2013.02.043 (2013).

    Article  CAS  PubMed  Google Scholar 

  18. Bagga, D. et al. Influence of 4-week multi-strain probiotic administration on resting-state functional connectivity in healthy volunteers. Eur. J. Nutr. 58(5), 1821–1827. https://doi.org/10.1007/s00394-018-1732-z (2019).

    Article  CAS  PubMed  Google Scholar 

  19. Eickhoff, S. B. et al. Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty. Hum. Brain Mapp. 30(9), 2907–2926. https://doi.org/10.1002/hbm.20718 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  20. Banerjee, S., Chitty, C., Lee, Q. & Treur, J. An adaptive network model of the role of the microbiome-gut-brain axis in insomnia. Cogn. Syst. Res. 78, 106–121. https://doi.org/10.1016/j.cogsys.2022.12.002 (2023).

    Article  Google Scholar 

  21. Han, Y. et al. Vagus nerve and underlying impact on the gut microbiota-brain axis in behavior and neurodegenerative diseases. J. Inflamm. Res. 9(15), 6213–6230. https://doi.org/10.2147/JIR.S384949 (2022).

    Article  Google Scholar 

  22. Greene, J. G. Causes and consequences of degeneration of the dorsal motor nucleus of the vagus nerve in Parkinson’s disease. Antioxid. Redox Signal. 21, 649–667. https://doi.org/10.1089/ars.2014.5859 (2014).

    Article  CAS  PubMed  Google Scholar 

  23. Inserra, A., Rogers, G. B., Licinio, J. & Wong, M. L. The microbiota-inflammasome hypothesis of major depression. BioEssays 40, e1800027. https://doi.org/10.1002/bies.201800027 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sgritta, M. et al. Mechanisms underlying microbial-mediated changes in social behavior in mouse models of autism spectrum disorder. Neuron 101, 246–259. https://doi.org/10.1016/j.neuron.2018.11.018e246 (2019).

    Article  CAS  PubMed  Google Scholar 

  25. Broncel, A., Bocian, R., Kłos-Wojtczak, P., Kulbat-Warycha, K. & Konopacki, J. Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders. Brain Res. Bull. 155, 37–47. https://doi.org/10.1016/j.brainresbull.2019.11.011 (2020).

    Article  CAS  PubMed  Google Scholar 

  26. Hachem, L. D., Wong, S. M. & Ibrahim, G. M. The vagus afferent network: emerging role in translational connectomics. Neurosurg Focus. 45(3), E2. https://doi.org/10.3171/2018.6 (2018).

    Article  PubMed  Google Scholar 

  27. Mayer, E. A. Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12(8), 453–466. https://doi.org/10.1038/nrn3071 (2011).

    Article  CAS  PubMed  Google Scholar 

  28. Wang, Y. et al. Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms. Neurosci & Biobehav Rev 127, 37–53. https://doi.org/10.1016/j.neubiorev.2021.04.018 (2021).

    Article  CAS  Google Scholar 

  29. Kaelberer, M. M. et al. A gut-brain neural circuit for nutrient sensory transduction. Science 361, eaat5236. https://doi.org/10.1126/science.aat5236 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Briand, M. M., Gosseries, O., Staumont, B., Laureys, S. & Thibaut, A. Transcutaneous auricular vagal nerve stimulation and disorders of consciousness: A hypothesis for mechanisms of action. Front. Neurol. 25(11), 933. https://doi.org/10.3389/fneur.2020.00933 (2020).

    Article  Google Scholar 

  31. Liu, C. H. et al. Neural networks and the anti-inflammatory effect of transcutaneous auricular vagus nerve stimulation in depression. J. Neuroinflamm. 17(1), 54. https://doi.org/10.1186/s12974-020-01732-5 (2020).

    Article  Google Scholar 

  32. Zhang, H. et al. Cognitive function and brain activation before and after transcutaneous cervical vagus nerve stimulation in healthy adults: A concurrent tcVNS-fMRI study. Front. Psychol. 11(13), 1003411. https://doi.org/10.3389/fpsyg.2022.1003411 (2022).

    Article  Google Scholar 

  33. Sellaro, R., de Gelder, B., Finisguerra, A. & Colzato, L. S. Transcutaneous vagus nerve stimulation (tVNS) enhances recognition of emotions in faces but not bodies. Cortex; A J. Devot. Study Nervous Syst. Behav. 99, 213–223. https://doi.org/10.1016/j.cortex.2017.11.007 (2018).

    Article  Google Scholar 

  34. Monroe, J. F. et al. The fusiform response to faces: Explicit versus implicit processing of emotion. Hum. Brain Mapp. 34(1), 1–11. https://doi.org/10.1002/hbm.21406 (2013).

    Article  PubMed  Google Scholar 

  35. Jung, S. et al. Fusiform gyrus volume reduction associated with impaired facial expressed emotion recognition and emotional intensity recognition in patients with schizophrenia spectrum psychosis Psychiatry research. Neuroimaging 307, 111226. https://doi.org/10.1016/j.pscychresns.2020.111226 (2021).

    Article  PubMed  Google Scholar 

  36. Jacobs, H. I., Riphagen, J. M., Razat, C. M., Wiese, S. & Sack, A. T. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol. Aging. 36(5), 1860–1867. https://doi.org/10.1016/j.neurobiolaging.2015.02.023 (2015).

    Article  PubMed  Google Scholar 

  37. Utevsky, A. V., Smith, D. V. & Huettel, S. A. Precuneus is a functional core of the default-mode network. J. Neurosci. 34(3), 932–940. https://doi.org/10.1523/JNEUROSCI.4227-13.2014 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cavanna, A. E. & Trimble, M. R. The precuneus: A review of its functional anatomy and behavioural correlates. Brain 129(3), 564–583. https://doi.org/10.1093/brain/awl004 (2006).

    Article  PubMed  Google Scholar 

  39. Dadario, N. B. & Sughrue, M. E. The functional role of the precuneus. Brain 146(9), 3598–3607. https://doi.org/10.1093/brain/awad181 (2023).

    Article  PubMed  Google Scholar 

  40. Leech, R. & Sharp, D. J. The role of the posterior cingulate cortex in cognition and disease. Brain 137(1), 12–32. https://doi.org/10.1093/brain/awt162 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kumral, E., Bayam, F. E. & Özdemir, H. N. Cognitive and behavioral disorders in patients with precuneal infarcts. Eur Neurol 84(3), 157–167. https://doi.org/10.1159/000513098 (2021).

    Article  PubMed  Google Scholar 

  42. Eich, T. S., Lao, P. & Anderson, M. C. Cortical thickness in the right inferior frontal gyrus mediates age-related performance differences on an item-method directed forgetting task. Neurobiol. Aging 106, 95–102. https://doi.org/10.1016/j.neurobiolaging.2021.06.001 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Feng, X., Guo, J., Sigmon, H. C., Sloan, R. P., Brickman, A. M., Provenzano, F. A., Small, S. A., & Alzheimer’s Disease Neuroimaging Initiative (2020). Brain regions vulnerable and resistant to aging without Alzheimer’s disease. PloS One 15(7), e0234255. https://doi.org/10.1371/journal.pone.0234255

  44. Khan, M. A. W., Stephens, W. Z., Mohammed, A. D., Round, J. L. & Kubinak, J. L. Does MHC heterozygosity influence microbiota form and function?. PLoS One 14(5), e0215946. https://doi.org/10.1371/journal.pone.0215946 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Yao, X. et al. Association of gut microbiota enterotypes with blood trace elements in women with infertility. Nutrients 14(15), 3195. https://doi.org/10.3390/nu14153195 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Loh, J. S. et al. Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases. Sig Transduct Target Ther 9, 37. https://doi.org/10.1038/s41392-024-01743-1 (2024).

    Article  Google Scholar 

  47. Cryan, J. F. & Mazmanian, S. K. Microbiota-brain axis: Context and causality. Science 376(6596), 938–939. https://doi.org/10.1126/science.abo4442 (2022).

    Article  ADS  CAS  PubMed  Google Scholar 

  48. Ahmed, H. et al. Microbiota-derived metabolites as drivers of gut-brain communication. Gut Microbes 14(1), 2102878. https://doi.org/10.1080/19490976.2022.2102878 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Chen, T. et al. Fiber-utilizing capacity varies in Prevotella- versus Bacteroides-dominated gut microbiota. Sci. Rep. 7(1), 2594. https://doi.org/10.1038/s41598-017-02995-4 (2017).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  50. Chambers, E. S., Morrison, D. J. & Frost, G. Control of appetite and energy intake by SCFA: What are the potential underlying mechanisms?. Proc. Nutr. Soc. 74(3), 328–336. https://doi.org/10.1017/S0029665114001657 (2015).

    Article  CAS  PubMed  Google Scholar 

  51. Mansuy-Aubert, V. & Ravussin, Y. Short chain fatty acids: The messengers from down below. Front. Neurosci. 17, 1197759. https://doi.org/10.3389/fnins.2023.1197759 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  52. Bobes, J. et al. Oviedo sleep questionnaire (OSQ): A new semistructured interview for sleep disorders. Eur. Neuropsychopharmacol. 2, S162 (1998).

    Google Scholar 

  53. Antony, M. M. et al. Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol. Assess. 10, 176–181 (1998).

    Google Scholar 

  54. Folstein, M. F., Folstein, S. E. & McHugh, P. R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189–198 (1975).

    CAS  PubMed  Google Scholar 

  55. Lobo, A. et al. Cognocitive mini-test (a simple practical test to detect intellectual changes in medical patients). Actas Luso Esp Neurol. Psiquiatr. Cienc. Afines. 7, 189–202 (1979).

    CAS  PubMed  Google Scholar 

  56. Delorme, A. & Makeig, S. EEGLAB: An open-source toolbox for analysis of single-trial EEG dynamics. J. Neurosci. Methods 134, 9–21 (2004).

    PubMed  Google Scholar 

  57. Kothe, C. A. & Makeig, S. BCILAB: A platform for brain-computer interface development. J Neural Eng. 10(5), 056014. https://doi.org/10.1088/1741-2560/10/5/056014 (2013).

    Article  PubMed  Google Scholar 

  58. Pion-Tonachini, L., Kreutz-Delgado, K. & Makeig, S. ICLabel: An automated electroencephalographic independent component classifier, dataset, and website. Neuroimage 198, 181–197 (2019).

    PubMed  Google Scholar 

  59. Bigdely-Shamlo, N., Mullen, T., Kothe, C., Su, K.-M. & Robbins, K. A. The PREP pipeline: Standardized preprocessing for large-scale EEG analysis. Front. Neuroinform. 9, 16. https://doi.org/10.3389/fninf.2015.00016 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  60. Pascual-Marqui, R. D. et al. Assessing interactions in the brain with exact low-resolution electromagnetic tomography. Philos. Trans. A. Math. Phys. Eng. Sci. 369, 3768–3784. https://doi.org/10.1098/rsta.2011.0081 (2011).

    Article  ADS  MathSciNet  PubMed  Google Scholar 

  61. Fan, L. et al. The human brainnetome atlas: A new brain atlas based on connectional architecture. Cereb. Cortex 26(8), 3508–3526. https://doi.org/10.1093/cercor/bhw157 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  62. Pelleg, D. and Moore, A.W. X-Means: Extending K-Means with efficient estimation of the number of clusters. Proceedings of the 17th International Conference on Machine Learning, June 2000, San Francisco, 727–734 (2000).

Download references

Acknowledgements

We acknowledge Maria Garcia Beccaria and Alfonso de Gorostegui (Bioinformatics Unit. IMDEA Food Institute) for their support in bioinformatical and statistical analyses.The authors thank the volunteers for their participation and commitment in the study.

Author information

Author notes

  1. Ana Ramírez de Molina and M. Dolores del Castillo share last authorship.

Authors and Affiliations

  1. Computational Models of Intelligence group, Center for Automation and Robotics (CAR, CSIC-UPM), Consejo Superior de Investigaciones Científicas (CSIC), Ctra. Campo Real km 0.200, 28500, Arganda del Rey, Spain

    J. Ignacio Serrano, Ana Sobrino-Santos, Manuel Cebrián & M. Dolores del Castillo

  2. Molecular Oncology and Nutritional Genomics of Cancer Group, IMDEA Food Institute, CEI UAM+CSIC, Carretera de Cantoblanco, 8, 28049, Madrid, Spain

    Silvia Cruz-Gil, Cristina M. Fernández, Lara P. Fernández, Isabel Espinosa-Salinas, María-Jesús Latasa, Ricardo Ramos-Ruiz & Ana Ramírez de Molina

  3. GENYAL Platform on Nutrition and Health, IMDEA Food Institute, CEI UAM+CSIC, Carretera de Cantoblanco, 8, 28049, Madrid, Spain

    Cristina M. Fernández & Ricardo Ramos-Ruiz

  4. Centro Nacional de Investigaciones Oncológicas (CNIO), C. de Melchor Fernández Almagro, 3, Fuencarral-El Pardo, 28029, Madrid, Spain

    Carolina Maestre

  5. Fundación para la Investigación e Innovación Biomédica del Hospital, Universitario Infanta Sofía y Hospital Universitario del Henares (FIIB HUIS HHEN), Paseo de Europa 34, 28702, San Sebastián de los Reyes, Madrid, Spain

    María-Jesús Latasa

Authors

  1. J. Ignacio Serrano
  2. Silvia Cruz-Gil
  3. Cristina M. Fernández
  4. Lara P. Fernández
  5. Ana Sobrino-Santos
  6. Isabel Espinosa-Salinas
  7. Carolina Maestre
  8. María-Jesús Latasa
  9. Manuel Cebrián
  10. Ricardo Ramos-Ruiz
  11. Ana Ramírez de Molina
  12. M. Dolores del Castillo

Contributions

J.I.S.: conceptualization, methodology, software, verification, formal analysis, investigation, data curation, writing—original draft, visualization; S.C.-G.: conceptualization, methodology, investigation, resources, data curation, writing—original draft, visualization; C.M.F.: conceptualization, methodology, investigation, resources, data curation, writing—original draft; L.P.F.: conceptualization, methodology, investigation, resources; A.S.-S.: software, investigation, writing—review & editing; I.E.-S.: conceptualization, methodology, investigation, resources; C.M.: conceptualization, methodology, investigation, resources; M.-J.L.: conceptualization, methodology, funding acquisition; M.C.: validation, writing—review & editing, visualization; R.R.-R.: methodology, project administration, funding acquisition, supervision; A.R.d.M.: conceptualization, methodology, supervision; M.D.d.C.: conceptualization, methodology, verification, formal analysis, investigation, resources, writing—original draft, supervision.

Corresponding author

Correspondence to J. Ignacio Serrano.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serrano, J.I., Cruz-Gil, S., Fernández, C.M. et al. Gut microbiota profiles are associated with different spontaneous cortical activity in healthy older people. Sci Rep 15, 31590 (2025). https://doi.org/10.1038/s41598-025-16090-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41598-025-16090-6

Keywords